Why These Stocks Are in Spotlight Today?

Molson Coors Brewing Company Posts Profit, Beats Estimates

Molson Coors Brewing Company (NYSE:TAP)’s stock has inched down by 0.11% after it posted a profit of $158.8 million for its first quarter of 2016, driven by beer volume growth, lower cost of goods sold and brand building. The Denver based brewer’s EPS in the first quarter was $0.54 on revenue of $657.2 million, higher than the estimated EPS of $0.43 on $627.65 million in revenue. Sales volume also inclined by 2.1% to 5.75 million hectoliters in the first quarter. Among the funds we track, 53 held stakes in Molson Coors Brewing Company (NYSE:TAP) at the end of last year.

Mallinckrodt PLC Beats Q2 Estimates, Raises Full Year Guidance

Mallinckrodt PLC (NYSE:MNK)’s stock has advanced by 6% after the company posted EPS of $2.01 on revenue of $918 million for the second fiscal quarter, surpassing the analysts’ estimates of $1.72 and $874 million, respectively. In a statement, Mark Trudeau, the CEO of the Dublin-based drug maker, said that the strategy of buying under-resourced assets for underserved patients in areas of high unmet medical needs is working. Mallinckrodt also raised its 2016 guidance for diluted earnings per share to the range of $8.15 to $8.50 from the previous $7.85 – $8.30 range. John Paulson’s Paulson & Co owned more than 8.6 million shares of Mallinckrodt PLC at the end of last year. Paulson is among the 39 funds from our database that had long positions in the company heading into 2016.

CVS Health Corp Beats Estimates

CVS Health Corp (NYSE:CVS)’s strong demand of its pharmacy benefit management (PBM) services drove its revenue and profit in the first quarter of 2016. The drugstore chain reported EPS of $1.18, better than the expected $1.16. Net revenue increased 19% on the year to $43.22 billion, beating analysts’ estimates of $43 billion. Established store sales increased by 4.2% in the quarter. CVS Health’s business was also boosted because of its two major acquisitions in 2015. The company bought Omnicare for $10.4 billion and Target Corp.’s pharmacy business for $1.9 billion. Overall, 53 investors we track held shares of CVS Health Corp (NYSE:CVS) at the end of the last year. As of March, Eric Sprott’s Sprott Asset Management owns 402,000 shares of the company.

Disclosure: None